International developed-market equity ETFs remain a core building block for investors seeking geographic diversification beyond U.S. large-caps. The BNY Mellon International Equity ETF (BKIE) and the Schwab International Equity ETF (SCHF) compete directly for the same allocation dollar, both targeting large- and mid-cap stocks across developed markets outside the United States. Although their mandates appear nearly identical at first glance, their underlying indexes diverge in country classification, security count, and sector composition. Comparing these two funds clarifies how seemingly interchangeable products can produce materially different exposure profiles, cost structures, and relative positioning in the current macro environment. I also checked this using Tickeron’s AI Screener to see how the two line up on key metrics.
BKIE is a passively managed fund that seeks to track the Solactive GBS Developed Markets ex United States Large & Mid Cap USD Index. Launched in April 2020, it holds roughly 990 securities spanning developed markets outside the U.S. Its largest country weights are Japan (about 21%), Canada (about 12%), the United Kingdom, France, Germany, and Switzerland. Top holdings include ASML Holding, Roche, AstraZeneca, HSBC, Novartis, Nestlé, SAP, Royal Bank of Canada, Toyota, and Shell, with the top ten names representing only about 12% of assets — a sign of limited single-stock concentration. Sector allocation is led by financials (roughly 25%), followed by industrials (about 18%), health care, information technology, and consumer discretionary. The fund carries a 0.04% net expense ratio and is classified as non-diversified under securities regulations despite its broad basket.
SCHF is a passively managed fund designed to track the FTSE Developed ex US Index, a market-cap-weighted benchmark of large- and mid-cap stocks in developed markets outside the United States. Incepted in November 2009, it holds approximately 1,440 securities and is one of the largest and most liquid international equity ETFs, with AUM in the tens of billions of dollars. Its top holdings include Samsung Electronics, SK Hynix, ASML Holding, Roche, Shell, Novartis, HSBC, Royal Bank of Canada, AstraZeneca, and Nestlé. A defining feature is FTSE's classification of South Korea as a developed market, which gives the fund meaningful semiconductor and technology exposure. Sector allocation is led by financials (around 24%), industrials, and technology, with the latter materially higher than in BKIE. The net expense ratio is 0.03%.
Both funds sit at the intersection of several powerful macro themes. A weaker U.S. dollar at various points in recent cycles has historically buoyed foreign earnings when translated back into dollars, while persistent valuation gaps between international and U.S. equities have drawn renewed capital flows into developed-market exposure. Bank and insurance holdings benefit from higher-for-longer interest rates in several regions, supporting the heavy financials weighting shared by both funds. Meanwhile, the global semiconductor and artificial-intelligence investment cycle favors funds with meaningful technology exposure — an area where SCHF's South Korea holdings, including Samsung and SK Hynix, provide an advantage. Risks include currency fluctuations, geopolitical tensions, and region-specific economic slowdowns that can weigh on export-heavy markets such as Japan and Germany. From what I see, the technology tilt in one fund versus the other could matter more than investors initially expect in the current environment.
Across recent market cycles, the two funds have moved in close lockstep given their overlapping developed-market mandates, but their relative positioning has diverged along sector lines. SCHF's inclusion of South Korea and its higher technology weight have allowed it to capture more of the semiconductor and memory-chip rally, giving it a modestly stronger growth tilt during risk-on periods. BKIE, by contrast, skews slightly toward financials, industrials, and Japanese equities, which can provide relative resilience when value and cyclical sectors lead. From a volatility standpoint, both funds carry comparable beta profiles, but SCHF's deeper liquidity and tighter trading spreads translate into lower total cost of ownership for larger positions and more efficient execution for institutional and active traders alike. I’m watching this closely because liquidity differences can show up in real trading costs over time.
When comparing funds like these, I often turn to Tickeron’s AI Screener to quickly surface differences in holdings, sector weights, and technical signals. It helps filter thousands of securities using customizable criteria such as industry exposure, performance metrics, and AI-driven patterns, making side-by-side evaluations more efficient. In this case, it reinforced the structural edge for one fund over the other based on diversification and liquidity data. Explore the AI Screener to refine your own screening process and identify comparable opportunities.
Weighing structural strength, cost efficiency, diversification breadth, liquidity, and sector momentum, Tickeron's AI would currently lean toward SCHF. Its slightly lower expense ratio, broader holdings count, deeper trading liquidity, and incremental technology and semiconductor exposure provide a marginal but consistent structural edge. The probability-weighted assessment favors SCHF for most investors seeking a diversified, low-cost developed-market core holding, while BKIE remains a competitive alternative for those preferring a financials- and Japan-heavy profile. This conclusion reflects observable fund characteristics rather than a forecast of near-term price moves.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The Moving Average Convergence Divergence (MACD) for SCHF turned positive on November 09, 2026. Looking at past instances where SCHF's MACD turned positive, the stock continued to rise in 36 of 42 cases over the following month. The odds of a continued upward trend are 86%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 58 cases where SCHF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
Following a +0.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where SCHF advanced for three days, in 275 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
SCHF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SCHF as a result. In 72 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SCHF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Aroon Indicator for SCHF entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows